1. Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations
- Author
-
Creary, Lisa E, Gangavarapu, Sridevi, Caillier, Stacy J, Cavalcante, Paola, Frangiamore, Rita, Lie, Benedicte A, Bengtsson, Mats, Harbo, Hanne Flinstad, Brauner, Susanna, Hollenbach, Jill A, Oksenberg, Jorge R, Bernasconi, Pia, Maniaol, Angelina Hatlø, Hammarström, Lennart, Mantegazza, Renato, and Fernández-Viña, Marcelo A
- Subjects
Biological Sciences ,Biomedical and Clinical Sciences ,Genetics ,Rare Diseases ,Autoimmune Disease ,Myasthenia Gravis ,Neurosciences ,Clinical Research ,Human Genome ,2.1 Biological and endogenous factors ,Aetiology ,Adult ,Age of Onset ,Alleles ,Female ,Genetic Predisposition to Disease ,HLA-B Antigens ,HLA-DR Antigens ,Haplotypes ,High-Throughput Nucleotide Sequencing ,Humans ,Italy ,Male ,Middle Aged ,Norway ,Sweden ,myasthenia gravis ,human leukocyte antigen ,next-generation sequencing ,European ,susceptibility ,protection ,Immunology ,Medical Microbiology ,Biochemistry and cell biology - Abstract
Genetic susceptibility to myasthenia gravis (MG) associates with specific HLA alleles and haplotypes at the class I and II regions in various populations. Previous studies have only examined alleles at a limited number of HLA loci that defined only broad serotypes or alleles defined at the protein sequence level. Consequently, genetic variants in noncoding and untranslated HLA gene segments have not been fully explored but could also be important determinants for MG. To gain further insight into the role of HLA in MG, we applied next-generation sequencing to analyze sequence variation at eleven HLA genes in early-onset (EO) and late-onset (LO) non-thymomatous MG patients positive for the acetylcholine receptor (AChR) antibodies and ethnically matched controls from Italy, Norway, and Sweden. For all three populations, alleles and haplotype blocks present on the ancestral haplotype AH8.1 were associated with risk in AChR-EOMG patients. HLA-B*08:01:01:01 was the dominant risk allele in Italians (OR = 3.28, P = 1.83E-05), Norwegians (OR = 3.52, P = 4.41E-16), and in Swedes HLA-B*08:01 was the primary risk allele (OR = 4.24, P
- Published
- 2021